US scientists believe they have found a drug that will reverse the effects of Alzheimer's, after trials on mice proved successful.
The team from the National Institute of Neurological Disorders and Stroke administered the TFP5 molecule to mice that had been specially engineered to experience a version of Alzheimer's disease. Their research is published in the latest edition of the Federation of American Societies for Experimental Biology journal.
After a series of injections to the abdominal region, the mice began to experience "restoration of memory loss" and reduction in other symptoms, without displaying any evidence of side-effects.
TFP5 works by preventing the overactive brain signal present in Alzheimer's patients that leads to a build-up of harmful plaques in the brain.
Editor of the journal Gerald Weissmann said: "Now that we know that we can target the basic molecular defects in Alzheimer’s disease, we can hope for treatments far better - and more specific - than anything we have today."
Find out more about Alzheimer's disease care at Barchester homes.